phase readout
saveNCT04146064: Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
COMPLETEDupdated 12m ago
community read0 votes
Sponsor: University Health Network, Toronto. Phase: . Conditions: NSCLC, Melanoma, Kidney Cancer, Urothelial Carcinoma, Head and Neck Cancer
view source ↗
comments(0)
5-min edit window · permanent after that